Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest

Experimental and Therapeutic Medicine

Volumn 9, Issue 5, 2015, Pages 1709-1718

  Li, Nan ^a   Zheng, Donghai ^b   Xue, Jie ^a   Guo, Weixing ^a   Shi, Jie ^a   Sun, Juxian ^a   Lu, Chongde ^a   Zheng, Weida ^b   Wu, Meng Chao ^a   Cheng, Shuqun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cidan; Cyclooxygenase 2; Primary hepatocellular carcinoma; Rhizoma Curcumae; Vascular endothelial growth factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; CIDAN; CYCLOOXYGENASE 2; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; PHOSPHATIDYLCHOLINE; POLYENE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL MIGRATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA TRANSCRIPTION; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; MTT ASSAY; NONHUMAN; OVERALL SURVIVAL; POSTOPERATIVE CARE; QUALITY OF LIFE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION;

EID: 84925068226     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2351     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Darvesh AS, Aggarwal BB and Bishayee A: Curcumin and liver cancer: a review. Curr Pharm Biotechnol 13: 218-228, 2012.
3. Li W, Gao Z, Yang C, et al: The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PloS One 8: e73472, 2013.
4. Su Y, Norris JL, Zang C, Peng Z and Wang N: Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis. Hemodial Int 17: 532-541, 2013.
5. Chen WQ, Zheng RS and Zhang SW: Liver cancer incidence and mortality in China, 2009. Chin J Cancer 32: 162-169, 2013.
6. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003.
7. Cheng JH, Chang G and Wu WY: A controlled clinical study between hepatic arterial infusion with embolized curcuma aromatic oil and chemical drugs in treating primary liver cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 21: 165-167, 2001 (In Chinese).
8. Wang WX, Li TX, Ma H, et al: Tumoral cytotoxic and antioxidative phenylpropanoid glycosides in Smilax riparia A. DC. J Ethnopharmacol 149: 527-532, 2013.
9. Liang QL, Dai CC, Jiang JH, Tang YP and Duan JA: A new cytotoxic casbane diterpene from Euphorbia pekinensis. Fitoterapia 80: 514-516, 2009.
10. Fang R, Houghton PJ and Hylands PJ: Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines. J Ethnopharmacol 118: 257-263, 2008.
11. Duan JA, Wang L, Qian S, Su S and Tang Y: A new cytotoxic prenylated dihydrobenzofuran derivative and other chemical constituents from the rhizomes of Atractylodes lancea DC. Arch Pharm Res 31: 965-969, 2008.
12. Lin H, Liu J and Zhang Y: Developments in cancer prevention and treatment using traditional Chinese medicine. Front Med 5: 127-133, 2011.
13. Dong HY, Shao JW, Wang T, Guo YH and Yan LY: Effects on the activities and mRNA expression of CYP3A in rat's liver by four kinds of extracts from anti-cancer traditional Chinese medicines. Zhong Yao Cai 31: 68-71, 2008 (In Chinese).
14. Wang B, Peng XX, Sun R, et al: Systematic review of ß-elemene injection as adjunctive treatment for lung cancer. Chin J Integr Med 18: 813-823, 2012.
15. Dai ZJ, Tang W, Lu WF, et al: Antiproliferative and apoptotic effects of ß-elemene on human hepatoma HepG2 cells. Cancer Cell Int 13: 27, 2013.
16. Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, and Wang YT: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae-a review. J Ethnopharmacol 143: 406-411, 2012.
17. Wang Q, Luan W, Goz V, Burakoff SJ and Hiotis SP: Non-invasive in vivo imaging for liver tumour progression using an orthotopic hepatocellular carcinoma model in immunocompetent mice. Liver Int 31: 1200-1208, 2011.
18. Hu HS, Cheng SQ, Shi J, et al: Establishment and characterization of a human hepatocellular carcinoma cell line CSQT-1 derived from portal vein tumor thrombus. Di Er Jun Yi Da Xue Xue Bao 30: 1-4, 2009.
19. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
20. Bauer JS, Schreiner CL, Giancotti FG, Ruoslahti E and Juliano RL: Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J Cell Biol 116: 477-487, 1992.
21. Pang R, Tse E and Poon RT: Molecular pathways in hepatocellular carcinoma. Cancer Lett 240: 157-169, 2006.
22. Wong CM and Ng IO: Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28: 160-174, 2008.
23. Singh S and Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270: 24995-25000, 1995.
24. Libby P: Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65: S140-S146, 2007.
25. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B and Anand P: Potential of spice-derived phytochemicals for cancer prevention. Planta Med 74: 1560-1569, 2008.
26. Lu JJ, Dang YY, Huang M, Xu WS, Chen XP and Wang YT: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae-a review. J Ethnopharmacol 143: 406-411, 2012.
27. Xu WS, Dang YY, Guo JJ, et al: Furanodiene induces endoplasmic reticulum stress and presents antiproliferative activities in lung cancer cells. Evid Based Complement Alternat Med 2012: 426521, 2012.
28. Lee SJ and Langhans SA: Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis. BMC Cancer 12: 44, 2012.
29. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M and D'Alessandro N: Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-?B activation levels and in IAP gene expression. Cancer Lett 224: 53-65, 2005.
30. Tung YT, Chen HL, Lee CY, et al: Active component of Danshen (Salvia miltiorrhiza Bunge), tanshinone I, attenuates lung tumorigenesis via inhibitions of VEGF, cyclin A, and cyclin B expressions. Evid Based Complement Alternat Med 2013: 319247, 2013.
31. Nie YL, Liu KX, Mao XY, Li YL, Li J and Zhang MM: Effect of injection of Brucea javanica oil emulsion plus chemoradiotherapy for lung cancer: a review of clinical evidence. J Evid Based Med 5: 216-225, 2012.
32. Li XY: Immunomodulating components from chinese medicines. Pharm Biol 38 (Suppl 1): 33-40, 2000.